# FDA Inspection 1056187 - Daniel J Finn MD - June 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/daniel-j-finn-md/70d4db90-29af-4525-9182-a8c5e04254af
Source feed: FDA_Inspections

> FDA Inspection 1056187 for Daniel J Finn MD on June 11, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1056187
- Company Name: Daniel J Finn MD
- Inspection Date: 2018-06-11
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1259931 - 2025-01-24](https://www.keypedia.com/records/fda_inspections/daniel-j-finn-md/1d665d21-9e3c-4f36-8406-b5532d2e23c6)
- [FDA Inspection 1259931 - 2025-01-24](https://www.keypedia.com/records/fda_inspections/daniel-j-finn-md/a046c5eb-b255-4984-afdb-11a6a6dd5c3a)

Company: https://www.keypedia.com/companies/daniel-j-finn-md/08b62b1d-79fb-4aef-8ee9-0a797db3fb20

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d